Curi Wealth Management, LLC Eli Lilly & CO Transaction History

Curi Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $12,604 - $14,859	24 Added 4.94%	510 $297,000
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $57,815 - $79,706	-133 Reduced 21.49%	486 $261,000
Q2 2023 Jul 31, 2023	SELL	$350.74 - $468.98 $1,052 - $1,406	-3 Reduced 0.48%	619 $290,000
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $193,211 - $226,918	622 New	622 $213,000
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $41,809 - $49,090	-150 Reduced 35.29%	275 $89,000
Q1 2022 May 06, 2022	BUY	$234.69 - $291.66 $44,825 - $55,707	191 Added 81.62%	425 $121,000
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $52,614 - $65,295	234 New	234 $64,000
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $43,380 - $56,158	-264 Closed	0 $0
Q4 2020 Mar 19, 2021	BUY	$130.46 - $172.63 $34,441 - $45,574	264 New	264 $44,000

4,073

737M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $771B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Curi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Curi Wealth Management, LLC with notifications on news.